Delta 9 Cannabis: Top 10 Undervalued Nano Cap Stocks on TSX (DN)
Delta 9 Cannabis is now ranked among the top 10 nano cap stocks on the Toronto Stock Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below). Nano caps total market capitalization (<50M).
All data provided as-at market close January 05, 2023. The list is sorted by stocks with the greatest percentage difference between valuation and price. Delta 9 Cannabis Delta 9 Cannabis Inc is a Canada-based company engaged in Biotechnology and Medical Research. The company is a licensed producer of medical marijuana and operates a production facility in Winnipeg, Manitoba. Delta 9 Cannabis is listed under DN on the Toronto Stock Exchange.
| Symbol | Name | Close Price | Shares Outstanding | P/E | P/B | Cash per Share | Net Cash per Share |
|---|---|---|---|---|---|---|---|
| DN-T | Delta 9 Cannabis | 0.07 | 0 | 0 | 0 | 0 | 0 |
| SMT-T | Sierra Metals | 0.24 | 0 | 0 | 0 | 0 | 0 |
| GLG-T | GLG Life Tech | 0.03 | 0 | 0 | 0 | 0 | 0 |
| FLNT-T | Flint | 0.04 | 0 | 0 | 0 | 0 | 0 |
| SBN-T | S Split | 3.33 | 0 | 0 | 0 | 0 | 0 |
| LPEN-T | Loop Energy | 1.02 | 0 | 0 | 0 | 0 | 0 |
| SGLD-T | Sabre Gold Mines | 0.16 | 0 | 0 | 0 | 0 | 0 |
| LSPK-T | LifeSpeak | 0.9 | 0 | 0 | 0 | 0 | 0 |
| ASP-T | Acerus Pharmaceuticals | 0.34 | 0 | 0 | 0 | 0 | 0 |
| WLLW-T | Willow Biosciences | 0.11 | 0 | 0 | 0 | 0 | 0 |
More about Delta 9 Cannabis
Stocks in this category are held primarily for capital appreciation. Nano, micro, and small cap stocks can be very volatile and may generate high returns or losses. Whereas mid and large cap stocks tend to be more stable.
Artificial intelligence at Report on Business
Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
